| High Yield Production Process for Shigella Outer Membrane Particles F Berlanda Scorza, AM Colucci, L Maggiore, S Sanzone, O Rossi, ... PloS one 7 (6), e35616, 2012 | 165 | 2012 |
| Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB C Gerke, AM Colucci, C Giannelli, S Sanzone, CG Vitali, L Sollai, O Rossi, ... PloS one 10 (8), e0134478, 2015 | 158 | 2015 |
| OMV vaccines and the role of TLR agonists in immune response F Mancini, O Rossi, F Necchi, F Micoli International journal of molecular sciences 21 (12), 4416, 2020 | 116 | 2020 |
| An O Antigen Capsule Modulates Bacterial Pathogenesis in Shigella sonnei M Caboni, T Pedron, O Rossi, D Goulding, D Pickard, F Citiulo, ... PLoS pathogens 11 (3), e1004749, 2015 | 104 | 2015 |
| Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella F Micoli, S Rondini, R Alfini, L Lanzilao, F Necchi, A Negrea, O Rossi, ... Proceedings of the National Academy of Sciences 115 (41), 10428-10433, 2018 | 103 | 2018 |
| Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in … O Rossi, I Pesce, C Giannelli, S Aprea, M Caboni, F Citiulo, S Valentini, ... Journal of Biological Chemistry 289 (36), 24922-24935, 2014 | 96 | 2014 |
| Toll-like receptor activation by generalized modules for membrane antigens from lipid A mutants of Salmonella enterica serovars Typhimurium and Enteritidis O Rossi, M Caboni, A Negrea, F Necchi, R Alfini, F Micoli, A Saul, ... Clinical and Vaccine Immunology 23 (4), 304-314, 2016 | 82 | 2016 |
| A broadly-protective vaccine against meningococcal disease in sub-Saharan Africa based on generalized modules for membrane antigens (GMMA) O Koeberling, E Ispasanie, J Hauser, O Rossi, G Pluschke, DA Caugant, ... Vaccine 32 (23), 2688-2695, 2014 | 71 | 2014 |
| GMMA-based vaccines: the known and the unknown F Mancini, F Micoli, F Necchi, M Pizza, F Berlanda Scorza, O Rossi Frontiers in Immunology 12, 715393, 2021 | 47 | 2021 |
| Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults RW Frenck, V Conti, P Ferruzzi, AGW Ndiaye, S Parker, MM McNeal, ... EClinicalMedicine 39, 2021 | 42 | 2021 |
| Antibodies Elicited by the Shigella sonnei GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results From a Phase 1 Dose … F Micoli, O Rossi, V Conti, O Launay, AS Sciré, MG Aruta, UN Nakakana, ... Frontiers in Immunology 12, 671325, 2021 | 34 | 2021 |
| Outer membrane vesicles: Moving within the intricate labyrinth of assays that can predict risks of reactogenicity in humans O Rossi, F Citiulo, F Mancini Human Vaccines & Immunotherapeutics 17 (2), 601-613, 2021 | 33 | 2021 |
| Comparison of colorimetric assays with quantitative amino acid analysis for protein quantification of Generalized Modules for Membrane Antigens (GMMA) O Rossi, L Maggiore, F Necchi, O Koeberling, CA MacLennan, A Saul, ... Molecular biotechnology 57, 84-93, 2015 | 25 | 2015 |
| Dissecting the contribution of O-Antigen and proteins to the immunogenicity of Shigella sonnei generalized modules for membrane antigens (GMMA) F Mancini, G Gasperini, O Rossi, MG Aruta, MM Raso, R Alfini, M Biagini, ... Scientific reports 11 (1), 906, 2021 | 24 | 2021 |
| Intra-laboratory evaluation of luminescence based high-throughput serum bactericidal assay (L-SBA) to determine bactericidal activity of human sera against Shigella O Rossi, E Molesti, A Saul, C Giannelli, F Micoli, F Necchi High-throughput 9 (2), 14, 2020 | 24 | 2020 |
| Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) reveals highly pure preparations L Maggiore, L Yu, U Omasits, O Rossi, G Dougan, NR Thomson, A Saul, ... International Journal of Medical Microbiology 306 (2), 99-108, 2016 | 24 | 2016 |
| Within-host spatiotemporal dynamics of systemic Salmonella infection during and after antimicrobial treatment O Rossi, R Dybowski, DJ Maskell, AJ Grant, O Restif, P Mastroeni Journal of Antimicrobial Chemotherapy 72 (12), 3390-3397, 2017 | 23 | 2017 |
| Salmonella Paratyphi A Outer Membrane Vesicles Displaying Vi Polysaccharide as a Multivalent Vaccine against Enteric Fever G Gasperini, R Alfini, V Arato, F Mancini, MG Aruta, P Kanvatirth, ... Infection and Immunity 89 (4), 10.1128/iai. 00699-20, 2021 | 22 | 2021 |
| Antibodies and Protection in Systemic Salmonella Infections: Do We Still Have More Questions than Answers? P Mastroeni, O Rossi Infection and Immunity 88 (10), 10.1128/iai. 00219-20, 2020 | 18 | 2020 |
| Stability of outer membrane vesicles-based vaccines, identifying the most appropriate methods to detect changes in vaccine potency E Palmieri, V Arato, D Oldrini, B Ricchetti, MG Aruta, W Pansegrau, ... Vaccines 9 (3), 229, 2021 | 17 | 2021 |
Allan SaulDirector of GSK Vaccines Institute for Global Health在 gsk.com 的电子邮件经过验证
